Influenza H1N1 seasonal influenza vaccine (Inovio)

N/A

Report date: 2022/08/30 20:00:42

Base Information

Drug NameInfluenza H1N1 seasonal influenza vaccine (Inovio)
Drug Alias NameSynCon H1HA consensus DNA vaccine (Inovio)SynCon universal H1N1 influenza vaccineINO-3609FVH-1INO-3605
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of PennsylvaniaInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A